EP-1329: IG-SBRT for localized prostate cancer: clinical results and late toxicity of a phase-II study. (May 2017) - Magli, A.; Moretti, E.; Tullio, A.; Foti, C.; Crespi, M.; Urpis, M.; Prisco, A.; Malisan, M.R.